101 related articles for article (PubMed ID: 29784390)
1. Simply and sensitively simultaneous detection hepatocellular carcinoma markers AFP and miRNA-122 by a label-free resonance light scattering sensor.
Chen F; Zhang F; Liu Y; Cai C
Talanta; 2018 Aug; 186():473-480. PubMed ID: 29784390
[TBL] [Abstract][Full Text] [Related]
2. One-step detection for two serological biomarker species to improve the diagnostic accuracy of hepatocellular carcinoma.
Gao T; Zhi J; Mu C; Gu S; Xiao J; Yang J; Wang Z; Xiang Y
Talanta; 2018 Feb; 178():89-93. PubMed ID: 29136911
[TBL] [Abstract][Full Text] [Related]
3. Color-Encoded Assays for the Simultaneous Quantification of Dual Cancer Biomarkers.
Ma J; Zhan L; Li RS; Gao PF; Huang CZ
Anal Chem; 2017 Aug; 89(16):8484-8489. PubMed ID: 28732160
[TBL] [Abstract][Full Text] [Related]
4. An electrochemical biosensor for the assay of alpha-fetoprotein-L3 with practical applications.
Li J; Gao T; Gu S; Zhi J; Yang J; Li G
Biosens Bioelectron; 2017 Jan; 87():352-357. PubMed ID: 27587360
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
6. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
[TBL] [Abstract][Full Text] [Related]
7. Multi-marker diagnosis method for early Hepatocellular Carcinoma based on surface plasmon resonance.
Yu H; Han R; Su J; Chen H; Li D
Clin Chim Acta; 2020 Mar; 502():9-14. PubMed ID: 31837298
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.
Riaz A; Ryu RK; Kulik LM; Mulcahy MF; Lewandowski RJ; Minocha J; Ibrahim SM; Sato KT; Baker T; Miller FH; Newman S; Omary R; Abecassis M; Benson AB; Salem R
J Clin Oncol; 2009 Dec; 27(34):5734-42. PubMed ID: 19805671
[TBL] [Abstract][Full Text] [Related]
9. Label-free detection of biomarker alpha fetoprotein in serum by ssDNA aptamer functionalized magnetic nanoparticles.
Su Y; Xue T; Wu L; Hu Y; Wang J; Xu Q; Chen Y; Lin Z
Nanotechnology; 2020 Feb; 31(9):095104. PubMed ID: 31726443
[TBL] [Abstract][Full Text] [Related]
10. A sensitive, universal and homogeneous method for determination of biomarkers in biofluids by resonance light scattering correlation spectroscopy (RLSCS).
Lan T; Dong C; Huang X; Ren J
Talanta; 2013 Nov; 116():501-7. PubMed ID: 24148436
[TBL] [Abstract][Full Text] [Related]
11. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
12. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
13. Testing for AFP in combination with ultrasound improves early liver cancer detection.
Tzartzeva K; Singal AG
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):947-949. PubMed ID: 30118333
[No Abstract] [Full Text] [Related]
14. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
Abbasi A; Bhutto AR; Butt N; Munir SM
J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
[TBL] [Abstract][Full Text] [Related]
15. Significant biomarkers for the management of hepatocellular carcinoma.
Kondo Y; Kimura O; Shimosegawa T
Clin J Gastroenterol; 2015 Jun; 8(3):109-15. PubMed ID: 25855582
[TBL] [Abstract][Full Text] [Related]
16. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
17. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
19. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Liu WH; Ren LN; Wang X; Wang T; Zhang N; Gao Y; Luo H; Navarro-Alvarez N; Tang LJ
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1767-78. PubMed ID: 25724413
[TBL] [Abstract][Full Text] [Related]
20. Magnetic-bioluminescent-nanoliposomes for ultrasensitive and portable detection of protein biomarkers in blood.
Liu P; Fang X; Cao H; Gu M; Kong J; Deng A
Anal Chim Acta; 2018 Dec; 1039():98-107. PubMed ID: 30322558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
